Form 4: Lisata Therapeutics Director Gregory B. Brown Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Gregory B. Brown reports acquisition of restricted stock units and changes in beneficial ownership of Lisata Therapeutics, Inc. stock.
Summary
- On January 9, 2025, Gregory B. Brown, a director of Lisata Therapeutics, Inc., reported changes in his beneficial ownership of the company's stock.
- Brown acquired 15,789 restricted stock units (RSUs) under the Issuer's 2018 Equity Incentive Compensation Plan.
- These RSUs will vest on January 9, 2026.
- Following the reported transaction, Brown beneficially owns 65,203 shares of common stock, including 15,789 unvested RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the sentiment is neutral. It simply reports a transaction.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership by a company insider, which is a common occurrence in publicly traded companies. It provides transparency to investors regarding the holdings of key individuals within the company.
Stakeholder Impact
- The change in ownership may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 01/09/2025 | Date of transaction: Acquisition of 15,789 restricted stock units. |
| 01/09/2026 | Vesting date for the 15,789 restricted stock units. |
| 01/13/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.